An IgM antibody against a tumour‐specific isoform of CD55 has been found to promote gastric tumour regression by inducing apoptosis, without causing severe side effects [49]; therefore, CD55 inhibition, or its use as a ligand to induce apoptosis in lesions, may help to inhibit the progression of IM. Here, CD40LG is linked to gastric neoplasm.